NIH Obesity Research Funding Opportunities

Current Funding Opportunities

1. Posted: Oct. 4, 2021

   Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional)

   RFA-DK-21-025
2. Posted: Sept. 3, 2021

   Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)

   RFA-DK-21-026
3. Posted: Sept. 3, 2021

   Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

   PAR-21-332
4. Posted: Sept. 3, 2021

   Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

   PAR-21-331
5. Posted: Aug. 30, 2021

   NHLBI Announces Interest in Promoting Cardiovascular and Cardiometabolic Health in Early Stages of the Lifecourse: Pre-adolescence Through Adolescence to Young Adulthood

   NOT-HL-21-020
6. Posted: Aug. 11, 2021

   Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

   PAR-21-305
7. Posted: July 14, 2021

   Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

   RFA-DK-21-002
8. Posted: July 14, 2021

   Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)

   RFA-DK-21-003
9. Posted: July 6, 2021

   Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed)

   RFA-DK-21-014
10. Posted: July 6, 2021

    Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)

    RFA-CA-21-021
11. Posted: July 6, 2021

    Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed)

    RFA-CA-21-022
12. Posted: July 6, 2021

    Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)

    PAR-21-253
13. Posted: April 6, 2021

    Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being  

    NOT-OD-21-087
14. Posted: March 29, 2021

    Nutrition Obesity Research Centers (P30 Clinical Trial Optional)

    RFA-DK-21-015
15. Posted: March 10, 2021

    Notice of Special Interest (NOSI): Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health

    NOT-HD-20-032
16. Posted: July 23, 2020

    Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children

    NOT-DK-20-036
17. Posted: July 13, 2020

    Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed)

    NOT-DK-20-035
18. Posted: Sept. 16, 2019

    Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31)

    PAR-19-378
19. Posted: Sept. 16, 2019

    Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)

    PAR-19-379
20. Posted: May 21, 2019

    Notice of Special Interest (NOSI): Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development 

    NOT-HL-19-695
21. Posted: Jan. 7, 2019

    Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development 

    NOT-DK-19-007
22. Posted: Aug. 7, 2018

    Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) 

    PAR-18-893
23. Posted: Aug. 7, 2018

    Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

    PAR-18-892
24. Posted: Aug. 2, 2018

    New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)

    PAR-18-886
25. Posted: July 17, 2018

    Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) 

    PAR-18-857
26. Posted: July 17, 2018

    Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) 

    PA-18-856
27. Posted: May 15, 2018

    The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed) 

    PA-18-784
28. Posted: May 9, 2018

    Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)

    PA-18-776